2020 Generic and Specialty Drug Companies: Capabilities, Goals and Strategies
In the dynamic and fragmented Generic and Specialty Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly important...and can spell the difference between success and failure.
Our collection of strategic assessments of leading Generic and Specialty Drug companies provides significant competitor information, analysis and insight critical to the development and implementation of effective business, marketing and R&D programs. The assessments include latest organizational and management developments, acquisitions and divestitures, marketing tactics, financial results, strengths and weaknesses, and strategic directions.
Aurora Cannabis
Canopy Growth
Cronos Group
Curaleaf
Dr. Reddys Laboratories
Green Thumb
Merck
MomentaPharma
Mylan
Perrigo
Teva Pharma
Tilray
oetis
These reports will complement your internal competitor information gathering efforts with objective strategic analysis, data interpretation and insight.
The reports will also assist current competitors and potential market entrants in evaluating prospective acquisitions and joint venture candidates.
Global Covid-19 Vaccine Market – Analysis By Product Type, Patient Type, End User, By Region, By Country (2021 Edition): Market Insights, Competition and Forecast (2020-2030)
Executive Global Covid-19 vaccine Market will be valued at approximately USD 25 billion in the year 2024. The growing government support for vaccine development and the increasing involvement of global
USD 2000 View ReportGlobal Lenses for Myopia Control Market - Analysis By Lens Type, Contact Lens, Spectacle Lens, Age, Sales Channel, Distribution Channel, Region, Country (2021 Edition): Market Insights, Covid ñ19 Impact, Competition and Forecast (2020-2025)
Executive Global Lenses for Myopia Control Market was valued at USD 24943.84 Million in the year 2019. Global Lenses for Myopia Control market witnessed remarkable growth during the historical period
USD 2600 View Report2021 Generic and Specialty Drug Companies: Capabilities, Goals and Strategies
In the dynamic and fragmented Generic and Specialty Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies
USD 9500 View ReportFill The Form For Sample Request